Form 4: Ani Pharmaceuticals Director Sells Shares
Insider Transaction (Form 4)
Jeanne Thoma, a Director of Ani Pharmaceuticals Inc, sold 1,000 shares of common stock on September 11, 2026 for $71.53 per share.
Summary
- Open-market sale: disposed of 1,000 Common Stock at $71.53 ($71,530) on September 11, 2026; holds 26,762 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $71,530 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Jeanne Thoma — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-11 | Open-market sale | Common Stock | 1,000 | $72 | $71.5K | 26,762 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-11 | Open-market sale (1,000 shares) |
Keywords
insider transaction, Form 4, ANIP, ANI PHARMACEUTICALS INC, bearish, Jeanne Thoma
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.